J Nicholas O'Donnell

16PUBLICATIONS
21CO-AUTHORS
Medical infection agents (incl. prions)Microbiology not elsewhere classifiedPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Infectious agents
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Apr 24, 2026
Determining the Activity of Imipenem/Relebactam Plus Aztreonam Against Constitutive Pseudomonas-Derived Cephalosporinase- and Metallo-β-Lactamase-Producing Pseudomonas aeruginosa in a Hollow Fiber Infection Model.

|Apr 10, 2026
A novel mechanism of ceftolozane-tazobactam resistance in Pseudomonas aeruginosa mediated by L2 β-lactamase.

Preeti Garai, Sophia H Nozick, Caroline C Jozefczyk

|Aug 31, 2024
Combination therapy with IV fosfomycin for adult patients with serious Gram-negative infections: a review of the literature.

David A Butler, Nimish Patel, J Nicholas O'Donnell

|Nov 17, 2022
Pharmacokinetics of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase 1, Open-Label Study of Healthy Adults.

Thomas P Lodise, J Nicholas O'Donnell, Stephen Balevic

|Nov 17, 2022
Safety of Ceftazidime-Avibactam in Combination with Aztreonam (COMBINE) in a Phase I, Open-Label Study in Healthy Adult Volunteers.

Thomas P Lodise, J Nicholas O'Donnell, Shruti Raja

|Jun 21, 2022
New Perspectives on Antimicrobial Agents: Imipenem-Relebactam.

J Nicholas O'Donnell, Thomas P Lodise

Pageof 3

Frequent Collaborators

8 joint publications

Thomas P Lodise

5 joint publications

Nathaniel J Rhodes

4 joint publications

Marc H Scheetz

2 joint publications

Gwendolyn Pais